Craig Hopkinson
Technik-/Wissenschafts-/F&E-Leiter bei ALKERMES PLC
Vermögen: 3 Mio $ am 31.05.2024
Profil
Craig C. Hopkinson ist Chief Medical Officer & EVP-Research & Development bei Alkermes Plc. In der Vergangenheit hatte Dr. Hopkinson die Position des Senior VP & Head-Global Medical Affairs bei Vertex Pharmaceuticals, Inc. und des President-Eisai Value Maximization Systems bei Eisai, Inc. inne. Dr. Hopkinson erwarb einen Bachelor-Abschluss an der University of the Free State.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.02.2024 | 109 709 ( 0,06% ) | 3 Mio $ | 31.05.2024 |
Aktive Positionen von Craig Hopkinson
| Unternehmen | Position | Beginn |
|---|---|---|
| ALKERMES PLC | Technik-/Wissenschafts-/F&E-Leiter | 30.05.2017 |
Ehemalige bekannte Positionen von Craig Hopkinson
| Unternehmen | Position | Ende |
|---|---|---|
| ALBIREO PHARMA, INC. | Direktor/Vorstandsmitglied | 02.03.2023 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
| VERTEX PHARMACEUTICALS INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2017 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Präsident | 01.12.2012 |
Ausbildung von Craig Hopkinson
| University of the Free State | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALKERMES PLC | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
